## Review

### Summary

The paper proposes TimeWarn, an extension of RETAIN that incorporates variable-specific elapsed-time decay into visit-level and variable-level attention for six-hour-ahead sepsis prediction. The problem is clinically relevant, and the reported improvements over GRU-D and RETAIN on MIMIC-IV and eICU are potentially meaningful. However, the current description does not provide enough methodological detail to establish that the gains are valid, leakage-free, statistically reliable, or clinically useful.

### Strengths

- Addresses an important problem: irregular sampling in EHR data and early sepsis detection.
- Evaluates on two widely used ICU datasets.
- Includes both interpretable and time-aware baselines.
- Reports both AUROC and AUPRC.
- Includes an ablation of the proposed time-decay mechanism.
- The paper is generally well organized and easy to follow.

### Major concerns

1. **Insufficient definition of the prediction task and labels.**  
   The paper does not specify how sepsis onset is operationalized, how onset time is determined from cultures, antibiotics, and organ dysfunction, or how observations after onset are excluded. These choices can substantially affect performance and create label leakage.

2. **Potential information leakage is not adequately addressed.**  
   The paper should clearly state whether all features, medication orders, laboratory results, and timestamps are restricted to information available at the prediction time. In particular, using measurements around cultures, antibiotics, or organ dysfunction criteria may inadvertently encode the sepsis-label construction process.

3. **Unclear handling of irregular measurements.**  
   Measurements are grouped into hourly windows, but the exact aggregation, imputation, timestamp alignment, and treatment of multiple measurements within a window are unspecified. The definition of Δ as the time since the “most recent previous measurement” is also ambiguous for the first observation and for measurements within the same hourly window.

4. **Limited methodological novelty.**  
   The proposed mechanism is a relatively simple addition of learned exponential decay to RETAIN attention. It is related conceptually to GRU-D and other time-aware recurrent models. The paper should more clearly distinguish its contribution from existing decay, time-aware attention, and continuous-time methods.

5. **Questionable fairness of baseline comparisons.**  
   TimeWarn is tuned by a 72-configuration grid search, whereas baselines use hyperparameters from their original papers. This is not necessarily an equivalent optimization procedure across datasets. Baseline tuning, preprocessing, and model capacity should be described and standardized.

6. **Insufficient statistical analysis.**  
   Although neural models are evaluated over five seeds, no confidence intervals, paired statistical tests, bootstrap comparisons, or test-set variability are reported. The improvements of 0.013–0.016 AUROC may or may not be statistically meaningful.

7. **Interpretability claims are overstated.**  
   Attention weights are not automatically faithful explanations. Averaging attention over true positives does not demonstrate causal or predictive importance. The claim that lactate, respiratory rate, and mean arterial pressure are “components of established sepsis criteria” is imprecise: lactate is relevant to organ dysfunction and sepsis assessment, but is not a qSOFA component.

8. **Limited clinical evaluation.**  
   AUROC and AUPRC alone do not establish usefulness for an alerting system. The paper should report calibration, sensitivity and specificity at clinically meaningful operating points, alert frequency, lead-time distributions, and possibly decision-curve or utility analyses.

9. **Reproducibility details are missing.**  
   Important information is absent, including sequence length, feature normalization, imputation, exclusion criteria, handling of repeated ICU stays, class weighting, batch construction, exact label prevalence after temporal censoring, and implementation details for the baselines.

### Scores

| Criterion | Score |
|---|---:|
| Soundness | 45/100 |
| Novelty | 52/100 |
| Significance | 60/100 |
| Clarity | 78/100 |

**Final average:** **58.75/100**

### Recommendation

**Reject**

The topic is important and the reported results are promising, but the paper requires substantial additional methodological detail and validation before the performance claims can be considered reliable. A revised version should focus especially on leakage prevention, precise sepsis-label construction, fair baseline tuning, statistical significance, reproducibility, and clinically relevant evaluation.